Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121763417> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2121763417 endingPage "182" @default.
- W2121763417 startingPage "177" @default.
- W2121763417 abstract "BACKGROUND: Introduction of new drugs is a dynamic process with a high impact on consumption and expenditure. OBJECTIVE: To analyze the prescription of new drugs and the associated costs in public health care in Catalunya, Spain, in 2002. The analysis also attempts a perspective of consumption in relation to the grade of therapeutic innovation of the new drugs. METHODS: Prescription data on all 86 new drugs licensed for use during 1998–2002 were analyzed, using the prescription item as unit and the cost. RESULTS: Prescription for new drugs in 2002 represented 4% of overall items prescribed and 13% of the cost. The mean new drug item cost was ¢39, while that of overall drugs was ¢13. New drug item increase over the previous year was 18.6% compared with 5.2% of the overall drugs, and the proportional cost increased by 25.7% and 9.9%, respectively. Ten new drugs represented 55.1% of the expenditure of this group. Antiasthmatic drugs represented 20.7% of the expenditure on new drugs, angiotensin-receptor blockers represented 18.6%, antiaggregants 9.7%, and nonsteroidal antiinflammatory drugs 6.9%. New drugs providing significant or modest therapeutic improvement represented 25.6% of overall new drug items and 32.3% of their cost. CONCLUSIONS: New drugs have a mean cost growth rate greater than that of existing drugs, with only a quarter of them offering advantages over existing drugs. More detailed evaluations of new medications are warranted before they can be recommended for general use so that a better distribution of the limited resources available may be made when prescribing drugs that are newly available through prescription." @default.
- W2121763417 created "2016-06-24" @default.
- W2121763417 creator A5009377124 @default.
- W2121763417 creator A5014828756 @default.
- W2121763417 creator A5045537963 @default.
- W2121763417 creator A5053160760 @default.
- W2121763417 creator A5055017471 @default.
- W2121763417 creator A5070681324 @default.
- W2121763417 date "2005-01-01" @default.
- W2121763417 modified "2023-10-17" @default.
- W2121763417 title "The Impact of New Drug Introduction on Drug Expenditure in Primary Health Care in Catalunya, Spain" @default.
- W2121763417 cites W1519388475 @default.
- W2121763417 cites W1964748194 @default.
- W2121763417 cites W1991898597 @default.
- W2121763417 cites W2013782010 @default.
- W2121763417 cites W2033817488 @default.
- W2121763417 cites W2125003309 @default.
- W2121763417 cites W2145137957 @default.
- W2121763417 cites W2156121263 @default.
- W2121763417 cites W2336413601 @default.
- W2121763417 cites W3018213047 @default.
- W2121763417 cites W4244318901 @default.
- W2121763417 doi "https://doi.org/10.1345/aph.1e236" @default.
- W2121763417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15572601" @default.
- W2121763417 hasPublicationYear "2005" @default.
- W2121763417 type Work @default.
- W2121763417 sameAs 2121763417 @default.
- W2121763417 citedByCount "14" @default.
- W2121763417 countsByYear W21217634172012 @default.
- W2121763417 countsByYear W21217634172022 @default.
- W2121763417 crossrefType "journal-article" @default.
- W2121763417 hasAuthorship W2121763417A5009377124 @default.
- W2121763417 hasAuthorship W2121763417A5014828756 @default.
- W2121763417 hasAuthorship W2121763417A5045537963 @default.
- W2121763417 hasAuthorship W2121763417A5053160760 @default.
- W2121763417 hasAuthorship W2121763417A5055017471 @default.
- W2121763417 hasAuthorship W2121763417A5070681324 @default.
- W2121763417 hasConcept C160735492 @default.
- W2121763417 hasConcept C162324750 @default.
- W2121763417 hasConcept C177713679 @default.
- W2121763417 hasConcept C2426938 @default.
- W2121763417 hasConcept C2776865356 @default.
- W2121763417 hasConcept C2780035454 @default.
- W2121763417 hasConcept C2908647359 @default.
- W2121763417 hasConcept C2909998350 @default.
- W2121763417 hasConcept C2986740045 @default.
- W2121763417 hasConcept C50522688 @default.
- W2121763417 hasConcept C71924100 @default.
- W2121763417 hasConcept C98274493 @default.
- W2121763417 hasConcept C99454951 @default.
- W2121763417 hasConceptScore W2121763417C160735492 @default.
- W2121763417 hasConceptScore W2121763417C162324750 @default.
- W2121763417 hasConceptScore W2121763417C177713679 @default.
- W2121763417 hasConceptScore W2121763417C2426938 @default.
- W2121763417 hasConceptScore W2121763417C2776865356 @default.
- W2121763417 hasConceptScore W2121763417C2780035454 @default.
- W2121763417 hasConceptScore W2121763417C2908647359 @default.
- W2121763417 hasConceptScore W2121763417C2909998350 @default.
- W2121763417 hasConceptScore W2121763417C2986740045 @default.
- W2121763417 hasConceptScore W2121763417C50522688 @default.
- W2121763417 hasConceptScore W2121763417C71924100 @default.
- W2121763417 hasConceptScore W2121763417C98274493 @default.
- W2121763417 hasConceptScore W2121763417C99454951 @default.
- W2121763417 hasIssue "1" @default.
- W2121763417 hasLocation W21217634171 @default.
- W2121763417 hasLocation W21217634172 @default.
- W2121763417 hasOpenAccess W2121763417 @default.
- W2121763417 hasPrimaryLocation W21217634171 @default.
- W2121763417 hasRelatedWork W125540217 @default.
- W2121763417 hasRelatedWork W2363239846 @default.
- W2121763417 hasRelatedWork W2363997707 @default.
- W2121763417 hasRelatedWork W2372971383 @default.
- W2121763417 hasRelatedWork W2375721144 @default.
- W2121763417 hasRelatedWork W2381428072 @default.
- W2121763417 hasRelatedWork W2390851511 @default.
- W2121763417 hasRelatedWork W2415045121 @default.
- W2121763417 hasRelatedWork W3118951916 @default.
- W2121763417 hasRelatedWork W4382776068 @default.
- W2121763417 hasVolume "39" @default.
- W2121763417 isParatext "false" @default.
- W2121763417 isRetracted "false" @default.
- W2121763417 magId "2121763417" @default.
- W2121763417 workType "article" @default.